# Variation Among Grain Elevator Testing Sites and Analytical Cross-Reactivity of Commercial Immunoassay Kits for Deoxynivalenol Detection in Maize

**Authors:** Beatrice Gedion, Victor Limay-Rios, J. David Miller, David C. Hooker, Arthur W. Schaafsma

PMC · DOI: 10.3390/toxins18020081 · Toxins · 2026-02-04

## TL;DR

This study finds that inconsistent DON test results in maize come from antibody reactions and testing site differences, not the test kits themselves.

## Contribution

The study identifies two specific sources of variability in DON immunoassay results: antibody cross-reactivity and site-specific testing practices.

## Key findings

- Immunoassay kits differ in their response to DON derivatives, affecting measurement accuracy.
- Grain elevator testing sites showed up to 16% deviation in DON measurements compared to a reference method.
- Variability in test results is due to antibody specificity and testing practices, not kit unreliability.

## Abstract

Commercial immunoassay-based test kits are widely used for rapid screening of deoxynivalenol (DON) in maize; however, inconsistent results are frequently observed under commercial testing conditions. This study evaluated two distinct contributors to such variability: analytical cross-reactivity of commercial DON immunoassays and between-site variability arising from routine grain elevator testing practices. Under controlled laboratory conditions, all kits accurately measured DON but responded differently to co-occurring DON derivatives. In naturally contaminated maize, immunoassay results reflected the combined presence of DON and co-occurring derivatives, consistent with differences in antibody specificity. An interlaboratory comparison involving multiple grain elevators analyzing identical blinded samples demonstrated substantial between-site variability in reported DON concentrations, with about 16% of results deviating by more than ±20% from the LC–MS/MS reference value. Collectively, these findings show that inconsistent DON test outcomes arise from the combined effects of antibody cross-reactivity and site-specific testing variability, rather than from any unreliability of the analytical methods themselves. This finding highlights the importance of interpreting rapid DON measurements considering these factors.

## Linked entities

- **Chemicals:** deoxynivalenol (PubChem CID 40024)
- **Species:** Zea mays (taxon 4577)

## Full-text entities

- **Diseases:** 3ADON (MESH:C537153), injury to (MESH:D014947), 15ADON (MESH:D012559)
- **Chemicals:** 15-acetyldeoxynivalenol (MESH:C046760), DON + D3G (-), trichothecenes (MESH:D014255), water (MESH:D014867), D3G (MESH:C542050), 3-acetyldeoxynivalenol (MESH:C043247), DON (MESH:C007262), methanol (MESH:D000432), formic acid (MESH:C030544), acetonitrile (MESH:C032159)
- **Species:** Homo sapiens (human, species) [taxon 9606], Sus scrofa (pig, species) [taxon 9823], Fusarium graminearum (species) [taxon 5518]
- **Mutations:** G1322A, G1312A, G1316A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12944916/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12944916/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12944916/full.md

---
Source: https://tomesphere.com/paper/PMC12944916